Nomura Asset Management International’s BioNTech BNTX Stock Holding History

Nomura Asset Management International’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.2M	Sell	249,399 -10,334	-4%	-$973K	0.03%	559
2026 Q1	$23.1M	Buy	259,733 +38,204	+17%	+$3.93M	0.04%	517
2025 Q4	$21.1M	Buy	+221,529	New	+$22.3M	0.03%	565

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Nomura Asset Management International's BNTX Position: Q2 2026 in Review

Nomura Asset Management International reduced its BioNTech (BNTX) stake by 4% in Q2 2026, selling an estimated $973K and leaving 249,399 shares worth $23.2M. The position accounts for 0.03% of the portfolio, ranked #559.

Nomura Asset Management International first reported a position in BNTX in Q4 2025 and has held it in 3 quarters since. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Nomura Asset Management International held 249,399 shares of BioNTech worth $23.2M as of Q2 2026.
Nomura Asset Management International sold 10,334 BioNTech shares in Q2 2026, an estimated $973K.
BioNTech made up 0.03% of Nomura Asset Management International's portfolio in Q2 2026, its #559 holding.
Nomura Asset Management International first reported a position in BioNTech in Q4 2025 and has held it in 3 quarters since.
281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.